Enteric disease testing: Key market research findings
- The Americas dominates the market geographically
- Bacterial enteric disease segment accounts for a majority of the market revenue
- Key vendors – Alere, bioMérieux, Cepheid, and DiaSorin
Technvaio’s market research analysts predict the global enteric disease testing market to grow at a CAGR of almost 9% between 2016 and 2020. The growth in this market can be accredited to the availability of novel enteric testing platforms. The launch of novel diagnostic testing platforms will significantly contribute to market growth by simplifying procedures, enhancing ease of use, and saving the time and money of patients and healthcare providers. For example, in March 2015, Microbix Biosystems launched two new molecular diagnostic control panels that can be used for testing GI pathogens. During 2015, the global enteric disease testing market was dominated by the Americas with a market share of more than 50%. The presence of several reputed companies in the region coupled with the rising incidence of enteric diseases will fuel growth in the enteric disease testing market in the Americas during the forecast period.
The new market research report from Technavio presents a breakdown and analysis of the enteric disease testing segments based on the disease.
“The market is undergoing a shift from singleplex to multiplex testing. Multiplexing involves the analysis of two or more analytes or pathogens from samples while singleplex testing involves the use of a specific assay kit for the detection of one analyte or pathogen. Multiplexing is employed for IVD techniques, including immunoassays, clinical chemistry, and nucleic acid-based diagnostics. It effectively increases the accuracy of detection by reducing variations in the results,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Currently, the bacterial enteric disease segment dominates the global enteric disease testing market by accounting for a market share of around 80%. The high prevalence of GI diseases, such as diarrhea and typhoid fever, is expected to fuel the demand for bacterial enteric disease testing among patients during the forecast period.
The key vendors in the global enteric disease testing market include Alere, bioMérieux, Cepheid, and DiaSorin. The global enteric disease testing market is highly fragmented due to the presence of small and medium-sized vendors that provide enteric disease testing products. The emerging economies such as China, India, and Brazil represent new opportunities for vendors to launch their enteric disease test instrument and test kits. The vendors that have the capability to offer a comprehensive portfolio of products, based on different technologies, to meet the needs of end users are expected to gain maximum market traction during the forecast period.
A more detailed analysis is available in the Technvaio report, Global Enteric Disease Testing Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
